Home > Healthcare > Biotechnology > Biotechnology R&D > Preimplantation Genetic Testing (PGT) Market

Preimplantation Genetic Testing (PGT) Market Share

Report ID: GMI12034
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Preimplantation Genetic Testing Market Share

The market is characterized by the presence of several key players leveraging advanced technologies like NGS, array and other technologies comparative genomic hybridization to enhance the accuracy and efficiency of genetic screening. The market also sees emerging players focusing on innovative products and services to capture niche segments. Strategic partnerships, acquisitions, and continuous research and development efforts are common strategies to strengthen market position.

Preimplantation Genetic Testing Market Companies

Few of the prominent players operating in the preimplantation genetic testing industry include:

Agilent Technologies
Fulgent Genetics
Genea BIOMEDX
Illumina
Medicover Genetics
Natera
Revvity
RGI
Takara Bio
Thermo Fisher Scientific
Varinos
Virtus Health
Vitrolife Group (Igenomix)

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global preimplantation genetic testing industry was valued at USD 780.8 million in 2023 and is estimated to grow at a 9.4% CAGR from 2024 to 2032, driven by the increasing prevalence of genetic disorders in newborns and rising awareness of reproductive health.

The product segment dominated the market and is anticipated to grow at a 9.3% CAGR over the forecast period, as it includes essential reagents, sequencing kits, and testing consumables required for accurate embryo testing in IVF procedures.

U.S. accounted for USD 312.2 million in the North American preimplantation genetic testing industry in 2023 and is expected to maintain its dominance throughout the forecast period, attributed to the widespread adoption of advanced reproductive technologies and growing awareness of genetic screening.

Key players in the industry include Agilent Technologies, Fulgent Genetics, Genea BIOMEDX, Illumina, Medicover Genetics, Natera, and Revvity.